Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE.

Glioblastoma (GBM) is a deadly disease with few effective therapies. Although much has been learned about the molecular characteristics of the disease, this knowledge has not been translated into clinical improvements for patients. At the same time, many new therapies are being developed.